Dream Recall Linked to Early Alzheimer's Clues

Recent research indicates that a reduced ability to remember dreams may serve as an early indicator of Alzheimer's disease. Findings published in 'Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring' suggest that poor dream recall, when other factors are excluded, could signal early neurodegeneration and a heightened risk of cognitive decline. This self-reported loss of dream recall in cognitively normal individuals is considered analogous to subjective cognitive decline, a commonly accepted first symptom of Alzheimer's.

The study, conducted by the Queen Sofia Foundation and CIEN, tracked 1,049 mentally healthy older adults for over a decade. Participants underwent cognitive tests, blood tests, and MRI scans. The research revealed that individuals who struggled to recall their dreams more frequently exhibited Alzheimer's-linked biomarkers, such as elevated tau protein levels and the APOE4 gene. This association persisted regardless of performance on memory tests.

Furthermore, participants who could not recall dreams at the study's commencement experienced more rapid cognitive deterioration over the subsequent ten years. Researchers propose this link may be associated with alterations in the brain's default mode network (DMN), which is responsible for dream content generation and is compromised in the early stages of Alzheimer's. Therefore, the difficulty in recalling dreams might not be a memory issue, but rather an indication of impaired dream content generation, an even earlier occurrence in the disease process.

While not a diagnostic criterion, this finding offers a valuable clue for advancing early detection efforts in Alzheimer's research. Separately, research published in 'Neurology' has linked the flu jab to a significantly lower dementia risk in elderly individuals aged 65 and older, suggesting potential preventative measures may also contribute to brain health.